Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxim Kozlov

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Optics Express|June 22, 2013
Finite element simulation of a perturbed axial-symmetric whispering-gallery mode and its use for intensity enhancement with a nanoparticle coupled to a microtoroidAlex Kaplan, Matthew Tomes, Tal Carmon, et al.
Biomedicines|December 24, 2021
Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer DrugsElmira Vagapova, Maxim Kozlov, Timofey Lebedev, et al.
Pharmaceutics|April 26, 2025
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers ApoptosisPavel Spirin, Valeria Vedernikova, Tatsiana Volkava, et al.
Methods in Enzymology|January 10, 2004
Strategies and methods of cross-linking of RNA polymerase active centerArkadv Mustaev, Eugeny Zaychikov, Mikhail Grachev, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Optics Express|June 22, 2013
Finite element simulation of a perturbed axial-symmetric whispering-gallery mode and its use for intensity enhancement with a nanoparticle coupled to a microtoroidAlex Kaplan, Matthew Tomes, Tal Carmon, et al.
Biomedicines|December 24, 2021
Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer DrugsElmira Vagapova, Maxim Kozlov, Timofey Lebedev, et al.
Pharmaceutics|April 26, 2025
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers ApoptosisPavel Spirin, Valeria Vedernikova, Tatsiana Volkava, et al.
Methods in Enzymology|January 10, 2004
Strategies and methods of cross-linking of RNA polymerase active centerArkadv Mustaev, Eugeny Zaychikov, Mikhail Grachev, et al.
Pageof 2